{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:48:11Z","timestamp":1791384491055,"version":"4.3.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T00:00:00Z","timestamp":1536710400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12889-018-6021-5","type":"journal-article","created":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T06:04:35Z","timestamp":1536732275000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Risk factors for multidrug-resistant tuberculosis among tuberculosis patients in Serbia: a case-control study"],"prefix":"10.1186","volume":"18","author":[{"given":"Maja","family":"Stosic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejana","family":"Vukovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragan","family":"Babic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordana","family":"Antonijevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristie L.","family":"Foley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidora","family":"Vujcic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8257-3774","authenticated-orcid":false,"given":"Sandra Sipetic","family":"Grujicic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,12]]},"reference":[{"key":"6021_CR1","volume-title":"Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. WHO\/HTM\/TB\/2014.11","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. WHO\/HTM\/TB\/2014.11. Geneva: WHO; 2014."},{"key":"6021_CR2","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1476-072X-10-50","volume":"10","author":"Y Liu","year":"2011","unstructured":"Liu Y, Jiang S, Liu Y, Wang R, Li X, Yuan Z, Wang L, Xue F. Spatial epidemiology and spatial ecology study of worldwide drug-resistant tuberculosis. Int J Health Geogr. 2011;10:50.","journal-title":"Int J Health Geogr"},{"issue":"1","key":"6021_CR3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2471\/BLT.12.104588","volume":"91","author":"A Skrahina","year":"2013","unstructured":"Skrahina A, Hurevich H, Zalutskaya A, Sahalchyk E, Astrauko A, Hoffner S, et al. Multidrug-resistant tuberculosis in Belarus: the size of the problem and associated risk factors. Bull World Health Organ. 2013;91(1):36\u201345.","journal-title":"Bull World Health Organ"},{"issue":"3","key":"6021_CR4","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3201\/eid2103.141343","volume":"21","author":"G G\u00fcnther","year":"2015","unstructured":"G\u00fcnther G, van Leth F, Alexandru S, Altet N, Avsar K, Bang D, et al. Multidrug-resistant tuberculosis in Europe, 2010\u20132011. Emerg Infect Dis. 2015;21(3):409\u201316.","journal-title":"Emerg Infect Dis"},{"key":"6021_CR5","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1186\/1471-2458-12-536","volume":"12","author":"EA Obuku","year":"2012","unstructured":"Obuku EA, Meynell C, Kiboss-Kyeyune J, Blankley S, Atuhairwe C, Nabankema E, et al. Socio-demographic determinants and prevalence of tuberculosis knowledge in three slum populations of Uganda. BMC Public Health. 2012;12:536.","journal-title":"BMC Public Health"},{"issue":"10","key":"6021_CR6","doi-asserted-by":"publisher","first-page":"e110461","DOI":"10.1371\/journal.pone.0110461","volume":"9","author":"P Isaakidis","year":"2014","unstructured":"Isaakidis P, Das M, Kumar AMV, Peskett C, Khetarpal M, Bamne A, et al. Alarming levels of drug-resistant tuberculosis in HIV infected patients in metropolitan Mumbai, India. PLoS One. 2014;9(10):e110461.","journal-title":"PLoS One"},{"issue":"Suppl 4","key":"6021_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/00333549101250S407","volume":"125","author":"A Courtwright","year":"2010","unstructured":"Courtwright A, Norris TA. Tuberculosis and stigmatization: pathways and interventions. Public Health Rep. 2010;125(Suppl 4):34\u201342.","journal-title":"Public Health Rep"},{"issue":"8","key":"6021_CR8","doi-asserted-by":"publisher","first-page":"e105214","DOI":"10.1371\/journal.pone.0105214","volume":"9","author":"M Rifat","year":"2014","unstructured":"Rifat M, Milton AH, Hall J, Oldmeadow C, Islam MA, Husain A, et al. Development of multidrug pesistant tuberculosis in Bangladesh: a case-control study on risk factors. PLoS One. 2014;9(8):e105214.","journal-title":"PLoS One"},{"issue":"1","key":"6021_CR9","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1089\/mdr.2005.11.62","volume":"11","author":"M Casal","year":"2005","unstructured":"Casal M, Vaquero M, Rinder H, Tortoli E, Grosset J, R\u00fcsch-Gerdes S, et al. A case control study for multiple resistant tuberculosis: risk factors in four European countries. Microb Drug Resist. 2005;11(1):62\u20137.","journal-title":"Microb Drug Resist"},{"key":"6021_CR10","volume-title":"Annual TB Report for 2014. Belgrade, Serbia","author":"Ministry of Health of the Republic of Serbia","year":"2015","unstructured":"Ministry of Health of the Republic of Serbia. Annual TB Report for 2014. Belgrade, Serbia, 2015."},{"key":"6021_CR11","unstructured":"Statistical Office of the Republic of Serbia. \n                    http:\/\/www.stat.gov.rs\/en-US\/\n                    \n                  . Accessed 23 Feb 2018."},{"issue":"6","key":"6021_CR12","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.drup.2014.02.003","volume":"16","author":"M Zignol","year":"2013","unstructured":"Zignol M, Dara M, Dean AS, Falzon D, Dadu A, Kremer K, et al. Drug-resistant tuberculosis in the WHO European region: an analysis of surveillance data. Drug Resist Updat. 2013;16(6):108\u201315.","journal-title":"Drug Resist Updat"},{"issue":"2","key":"6021_CR13","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1136\/thx.2005.045963","volume":"61","author":"A Faustini","year":"2006","unstructured":"Faustini A, Hall AJ, Perucci CA. Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax. 2006;61(2):158\u201363.","journal-title":"Thorax"},{"key":"6021_CR14","volume-title":"Conceptual Guidelines and Instructions, Eurostat","author":"European Health Interview Survey wave 2","year":"2012","unstructured":"European Health Interview Survey wave 2 - Conceptual Guidelines and Instructions, Eurostat, 2012."},{"key":"6021_CR15","unstructured":"IBM Corp. Released 2011. IBM SPSS statistics for windows, version 20.0. Armonk: IBM Corp."},{"key":"6021_CR16","volume-title":"Results of the National Health Survey of the republic of Serbia 2013","author":"K Boricic","year":"2014","unstructured":"Boricic K, Vasic M, Grozdanov J. Results of the National Health Survey of the republic of Serbia 2013. Belgrade: Institute of Public Health of Serbia; 2014."},{"issue":"1","key":"6021_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s40249-016-0187-9","volume":"5","author":"B Getahun","year":"2016","unstructured":"Getahun B, Wubie M, Dejenu G, Manyazewal T. Tuberculosis care strategies and their economic consequences for patients: the missing link to end tuberculosis. Infect Dis Poverty. 2016;5(1):93.","journal-title":"Infect Dis Poverty"},{"issue":"4","key":"6021_CR18","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S1473-3099(15)00401-6","volume":"16","author":"A Siroka","year":"2016","unstructured":"Siroka A, Ponce NA, L\u00f6nnroth K. Association between spending on social protection and tuberculosis burden: a global analysis. Lancet Infect Dis. 2016;16(4):473\u20139.","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"6021_CR19","doi-asserted-by":"publisher","first-page":"790","DOI":"10.5588\/ijtld.16.0599","volume":"21","author":"JS Nery","year":"2017","unstructured":"Nery JS, Rodrigues LC, Rasella D, Aquino R, Barreira D, Torrens AW, et al. Effect of Brazil\u2019s conditional cash transfer programme on tuberculosis incidence. Int J Tuberc Lung Dis. 2017;21(7):790\u20136.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"6021_CR20","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1186\/s12889-017-4435-0","volume":"17","author":"G Harling","year":"2017","unstructured":"Harling G, Lima Neto AS, Sousa GS, Machado MMT, Castro MC. Determinants of tuberculosis transmission and treatment abandonment in Fortaleza. Brazil BMC Public Health. 2017;17(1):508.","journal-title":"Brazil BMC Public Health"},{"issue":"1","key":"6021_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40249-016-0214-x","volume":"6","author":"KT Kibret","year":"2017","unstructured":"Kibret KT, Moges Y, Memiah P, Biadgilign S. Treatment outcomes for multidrug-resistant tuberculosis under DOTS-plus: a systematic review and meta-analysis of published studies. Infect Dis Poverty. 2017;6(1):7.","journal-title":"Infect Dis Poverty."},{"key":"6021_CR22","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12889-016-2711-z","volume":"16","author":"C Zhang","year":"2016","unstructured":"Zhang C, Wang Y, Shi G, Han W, Zhao H, Zhang H, Xi X. Determinants of multidrug-resistant tuberculosis in Henan province in China: a case control study. BMC Public Health. 2016;16:42.","journal-title":"BMC Public Health"},{"issue":"9","key":"6021_CR23","doi-asserted-by":"publisher","first-page":"e008273","DOI":"10.1136\/bmjopen-2015-008273","volume":"5","author":"M Rifat","year":"2015","unstructured":"Rifat M, Hall J, Oldmeadow C, Husain A, Hinderaker SG, Milton AH. Factors related to previous tuberculosis treatment of patients with multidrug-resistant tuberculosis in Bangladesh. BMJ Open. 2015;5(9):e008273.","journal-title":"BMJ Open"},{"issue":"4","key":"6021_CR24","doi-asserted-by":"publisher","first-page":"229","DOI":"10.5455\/msm.2015.27.229-233","volume":"27","author":"KM Jadgal","year":"2015","unstructured":"Jadgal KM, Nakhaei-Moghadam T, Alizadeh-Seiouki H, Zareban I, Sharifi-Rad J. Impact of educational intervention on patients behavior with smear-positive pulmonary tuberculosis: a study using the health belief model. Mater Sociomed. 2015;27(4):229\u201333.","journal-title":"Mater Sociomed"},{"issue":"3","key":"6021_CR25","doi-asserted-by":"publisher","first-page":"373","DOI":"10.5588\/ijtld.12.0464","volume":"17","author":"HE Jenkins","year":"2013","unstructured":"Jenkins HE, Ciobanu A, Plesca V, Crudu V, Galusca I, Soltan V, Cohen T. Risk factors and timing of default from treatment for non-multidrug-resistant tuberculosis in Moldova. Int J Tuberc Lung Dis. 2013;17(3):373\u201380.","journal-title":"Int J Tuberc Lung Dis."},{"key":"6021_CR26","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1440-1843.2012.02257.x","volume":"18","author":"CC Kwok","year":"2013","unstructured":"Kwok CC, Wing WY. Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012. Respirology. 2013;18:8\u201321.","journal-title":"Respirology"},{"key":"6021_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1471-2334-8-97","volume":"8","author":"E Hasker","year":"2008","unstructured":"Hasker E, Khodjikhanov M, Usarova S, Asamidinov U, Yuldashova U, van der Werf MJ, et al. Default from tuberculosis treatment in Tashkent, Uzbekistan; who are these defaulters and why do they default? BMC Infect Dis. 2008;8:97.","journal-title":"BMC Infect Dis"},{"key":"6021_CR28","doi-asserted-by":"publisher","first-page":"891","DOI":"10.5588\/ijtld.11.0795","volume":"16","author":"AC Miller","year":"2012","unstructured":"Miller AC, Gelmanova IY, Keshavjee S, Atwood S, Yanova G, Mishustin S, Furin JJ, Shin SS. Alcohol use and the management of multi drug resistant tuberculosis in Tomsk, Russian Federation. Int J Tuberc Lung Dis. 2012;16:891\u20136.","journal-title":"Int J Tuberc Lung Dis"},{"key":"6021_CR29","first-page":"284","volume-title":"A Survival Guide for Clinicians. Curry International Tuberculosis Center and California Department of Public Health","author":"Drug-Resistant Tuberculosis","year":"2016","unstructured":"Drug-Resistant Tuberculosis. A Survival Guide for Clinicians. Curry International Tuberculosis Center and California Department of Public Health. 3rd ed; 2016. p. 284\u20139.","edition":"3"},{"issue":"5","key":"6021_CR30","doi-asserted-by":"publisher","first-page":"274","DOI":"10.11622\/smedj.2015054","volume":"56","author":"AP Chua","year":"2015","unstructured":"Chua AP, Lim LK, Ng H, Chee CB, Wang YT. Outcome of a grocery voucher incentive scheme for low-income tuberculosis patients on directly observed therapy in Singapore. Singap Med J. 2015;56(5):274\u20139.","journal-title":"Singap Med J"},{"issue":"1","key":"6021_CR31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1471-6712.2012.01009.x","volume":"27","author":"B G\u00e4rden","year":"2013","unstructured":"G\u00e4rden B, Samarina A, Stavchanskaya I, Alsterlund R, \u00d6vregaard A, Taganova O, et al. Food incentives improve adherence to tuberculosis drug treatment among homeless patients in Russia. Scand J Caring Sci. 2013;27(1):117\u201322.","journal-title":"Scand J Caring Sci"},{"key":"6021_CR32","first-page":"CD007952","volume":"9","author":"EE Lutge","year":"2015","unstructured":"Lutge EE, Wiysonge CS, Knight SE, Sinclair D, Volmink J. Incentives and enablers to improve adherence in tuberculosis. Cochrane Database Syst Rev. 2015;9:CD007952.","journal-title":"Cochrane Database Syst Rev"},{"issue":"10024","key":"6021_CR33","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0140-6736(15)00151-8","volume":"387","author":"K Dheda","year":"2016","unstructured":"Dheda K, Barry CE 3rd, Maartens G. Tuberculosis. Lancet. 2016;387(10024):1211\u201326.","journal-title":"Lancet"},{"key":"6021_CR34","volume-title":"WHO treatment guidelines fordrug-resistant tuberculosis. 2016 update","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. WHO treatment guidelines fordrug-resistant tuberculosis. 2016 update. Geneva: WHO; 2016."},{"issue":"11","key":"6021_CR35","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.jfma.2015.10.002","volume":"115","author":"MA Gadallah","year":"2016","unstructured":"Gadallah MA, Mokhtar A, Rady M, El-Moghazy E, Fawzy M, Kandil SK. Prognostic factors of treatment among patients with multidrug-resistant tuberculosis in Egypt. J Formos Med Assoc. 2016;115(11):997\u20131003.","journal-title":"J Formos Med Assoc"},{"key":"6021_CR36","volume-title":"Clinical diagnosis and management of tuberculosis and measures for its prevention and control","author":"National Collaborating Center for Chronic Conditions","year":"2006","unstructured":"National Collaborating Center for Chronic Conditions. Clinical diagnosis and management of tuberculosis and measures for its prevention and control. London: Royal College of Physicians; 2006."},{"key":"6021_CR37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2147\/IDR.S126274","volume":"10","author":"A Workicho","year":"2017","unstructured":"Workicho A, Kassahun W, Alemseged F. Risk factors for multidrug-resistant tuberculosis among tuberculosis patients: a case-control study. Infect Drug Resist. 2017;10:91\u20136.","journal-title":"Infect Drug Resist"},{"issue":"6","key":"6021_CR38","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1177\/0300060516687429","volume":"45","author":"XT Lv","year":"2017","unstructured":"Lv XT, Lu XW, Shi XY, Zhou L. Prevalence and risk factors of multi-drug resistant tuberculosis in Dalian. China J Int Med Res. 2017;45(6):1779\u201386.","journal-title":"China J Int Med Res"},{"key":"6021_CR39","volume-title":"WHO\/GLC monitoring Mission report of the implementation of the National M\/XDR TB response plan. WHO Regional Office for Europe","author":"M Danilovits","year":"2015","unstructured":"Danilovits M. WHO\/GLC monitoring Mission report of the implementation of the National M\/XDR TB response plan. WHO Regional Office for Europe, 2015."},{"key":"6021_CR40","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1471-244X-12-89","volume":"12","author":"K Peltzer","year":"2012","unstructured":"Peltzer K, Naidoo P, Matseke G, Louw J, Mchunu G, Tutshana B. Prevalence of psychological distress and associated factors in tuberculosis patients in public primary care clinics in South Africa. BMC Psychiatry. 2012;12:89.","journal-title":"BMC Psychiatry"},{"issue":"2","key":"6021_CR41","doi-asserted-by":"publisher","first-page":"378","DOI":"10.4314\/ahs.v15i2.10","volume":"15","author":"PB Xavier","year":"2015","unstructured":"Xavier PB, Peixoto B. Emotional distress in Angolan patients with several types of tuberculosis. Afr Health Sci. 2015;15(2):378\u201384.","journal-title":"Afr Health Sci"},{"key":"6021_CR42","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12888-015-0598-3","volume":"15","author":"B Duko","year":"2015","unstructured":"Duko B, Gebeyehu A, Ayano G. Prevalence and correlates of depression and anxiety among patients with tuberculosis at Wolaita Sodo University Hospital and Sodo Health Center, WolaitaSodo, South Ethiopia, Cross sectional study. BMC Psychiatry. 2015;15:214.","journal-title":"BMC Psychiatry"},{"issue":"1","key":"6021_CR43","doi-asserted-by":"publisher","first-page":"e0167559","DOI":"10.1371\/journal.pone.0167559","volume":"12","author":"S Khanal","year":"2017","unstructured":"Khanal S, Elsey H, King R, Baral SC, Bhatta BR, Newell JN. Development of a patient-Centred, psychosocial support intervention for multi-drug-resistant tuberculosis (MDR-TB) Care in Nepal. PLoS One. 2017;12(1):e0167559.","journal-title":"PLoS One"},{"issue":"8","key":"6021_CR44","doi-asserted-by":"publisher","first-page":"e0135205","DOI":"10.1371\/journal.pone.0135205","volume":"10","author":"JN Zhao","year":"2015","unstructured":"Zhao JN, Zhang XX, He XC, Yang GR, Zhang XQ, Xin WG, Li HC. Multidrug-resistant tuberculosis in patients with chronic obstructive pulmonary disease in China. PLoS One. 2015;10(8):e0135205.","journal-title":"PLoS One"},{"issue":"9728","key":"6021_CR45","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1016\/S0140-6736(10)60483-7","volume":"375","author":"K Lonnroth","year":"2010","unstructured":"Lonnroth K, Castro KG, Chakaya JM, Chauhan LS, Floyd K, Glaziou P, Raviglione MC. Tuberculosis control and elimination 2010-2050: cure, care, and social development. Lancet. 2010;375(9728):1814\u201329.","journal-title":"Lancet"},{"issue":"4","key":"6021_CR46","doi-asserted-by":"publisher","first-page":"e10138","DOI":"10.1371\/journal.pone.0010138","volume":"5","author":"M Inghammar","year":"2010","unstructured":"Inghammar M, Ekbom A, Engstr\u00f6m G, Ljungberg B, Romanus V, Lofdahl CG, Egesten A. COPD and the risk of tuberculosis: a population-based cohort study. PLoS One. 2010;5(4):e10138.","journal-title":"PLoS One"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-018-6021-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-018-6021-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-018-6021-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T19:08:37Z","timestamp":1568228917000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-018-6021-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,12]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["6021"],"URL":"https:\/\/doi.org\/10.1186\/s12889-018-6021-5","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,12]]},"assertion":[{"value":"27 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by Ethic Committee of the Special Hospital for Lung Diseases Ozren \u2013 Sokobanja (No 2002\/2014). Informed consent was given by participants at the beginning of the interview.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"1114"}}